HMGA2 and neoplasm: However, we did not observe evidence for accelerated tumor progression or a shift towards more aggressive lesions in the absence of functional CIC, as demonstrated by HMGA2 immunostaining as a marker for lung tumor progression and invasion (Fig. EV1C–E) (Winslow et al, 2011).